Latest News in the pharma Industry

Research & Development

Mylan and Biocon announce regulatory submission for insulin glargine accepted for eeview by EMA

Mylan and Biocon announce regulatory submission for insulin glargine accepted for eeview by EMA

3 Nov 2016

Filing includes analytical, functional and pre-clinical data, and results from the pharmacokinetics and confirmatory efficacy/safety global clinical trial in Type 2 diabetes patients comparing Mylan's and Biocon's Insulin glargine with Lantus.

Read more 
Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor

Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor

2 Nov 2016

Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders.

Read more 
Novartis LEE011 granted FDA Priority Review for first-line treatment of HR+/HER2- advanced breast cancer

Novartis LEE011 granted FDA Priority Review for first-line treatment of HR+/HER2- advanced breast cancer

2 Nov 2016

Trial showed LEE011 plus letrozole reduced the risk of progression or death by 44% over letrozole alone.

Read more 
Lynparza trial shows significant progression-free survival benefit for women with ovarian cancer

Lynparza trial shows significant progression-free survival benefit for women with ovarian cancer

1 Nov 2016

Access for Canadian women remains in jeopardy despite mounting evidence of significant clinical benefits of Lynparza.

Read more 
EMA validates the MAA for avelumab for the treatment of metastatic Merkel cell carcinoma

EMA validates the MAA for avelumab for the treatment of metastatic Merkel cell carcinoma

31 Oct 2016

If approved, avelumab, an investigational anti-PD-L1 IgG1, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma.

Read more 
Optibrium and Collaborative Drug Discovery partner on integration of StarDrop with CDD Vault

Optibrium and Collaborative Drug Discovery partner on integration of StarDrop with CDD Vault

31 Oct 2016

Collaboration provides a comprehensive platform for data management, analysis and compound design in drug discovery.

Read more 
GSK presents new data for shingles candidate vaccine

GSK presents new data for shingles candidate vaccine

27 Oct 2016

New studies support flexible dosing and co-administration with flu vaccine.

Read more 
Allergan to acquire GI disease subsidiary of Rhythm Holding Company

Allergan to acquire GI disease subsidiary of Rhythm Holding Company

27 Oct 2016

Acquisition expands Allergan's gastroenterology pipeline.

Read more 
Sanofi Pasteur, Fiocruz, and WRAIR to collaborate on Zika vaccine research

Sanofi Pasteur, Fiocruz, and WRAIR to collaborate on Zika vaccine research

27 Oct 2016

The three research organizations have a history of flavivirus vaccine collaboration.

Read more 
Skin patch to treat peanut allergy shows benefit in children

Skin patch to treat peanut allergy shows benefit in children

26 Oct 2016

NIH-funded study suggests patch is safe, convenient mode of treatment.

Read more 
Boehringer Ingelheim's adalimumab biosimilar candidate shows promise

Boehringer Ingelheim's adalimumab biosimilar candidate shows promise

26 Oct 2016

Phase III study established equivalence in efficacy and similar safety profile between BI 695501 and Humira (adalimumab) in patients with active rheumatoid arthritis.

Read more 
Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson

Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson

26 Oct 2016

Programs include a systematic approach to drug repurposing and data-driven, proactive chronic disease management - both fueled by the IBM Watson Health Cloud.

Read more